Markers of Vascular Function and Future Coronary Artery Disease Risk Among Malaysians with Individual Cardiovascular

Amilia Aminuddin1, Nina Diyana Rusanuar1, Md Rizman Md Lazin Md Lazim2

  • 1Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.

Biomedicines
|April 29, 2025
PubMed

Insights

Central vascular markers like pulse wave velocity (PWV) and augmentation index (AI) effectively detect coronary artery disease (CAD) risk, while peripheral measures like finger photoplethysmography fitness index (PPGF) offer insights into microvascular function, particularly in dyslipidemia.

Area of Science:

  • Cardiovascular Physiology
  • Vascular Biology
  • Biomedical Engineering

Background:

  • Vascular function markers, including central (PWV, AI) and peripheral (PPGF), detect early vascular damage linked to coronary artery disease (CAD) risk factors.
  • Hypertension (HPT), dyslipidemia, and obesity are significant CAD risk factors associated with vascular dysfunction.
  • Comparing these vascular markers across different risk factor groups is crucial for understanding their clinical relevance.

Purpose of the Study:

  • To compare central and peripheral vascular function marker levels in subjects with hypertension, dyslipidemia, and obesity.
  • To determine the relationship between vascular function markers and CAD risk factors within these groups.
  • To evaluate the utility of PWV, AI, and PPGF in assessing vascular health in individuals with common CAD risk factors.

Main Methods:

  • Recruitment of 320 subjects, including healthy controls and individuals with CAD risk factors.
  • Assessment of peripheral vascular function using finger photoplethysmography fitness index (PPGF).
  • Measurement of central vascular markers, including pulse wave velocity (PWV) and augmentation index (AI), and calculation of Framingham risk score (FRS).

Main Results:

  • PWV and AI were significantly elevated in hypertensive subjects compared to controls.
  • No significant differences in PPGF levels were observed between the groups.
  • PWV correlated with FRS in hypertension and dyslipidemia groups; AI correlated with FRS in the obesity group. PPGF associated with PWV and AI in dyslipidemia.

Conclusions:

  • PWV and AI are reliable macrovascular markers for arterial stiffness and systemic vascular resistance related to CAD risk.
  • PPGF, a microvascular marker, provides valuable insights into endothelial dysfunction and microcirculatory issues, especially in dyslipidemia.
  • Integrating central and peripheral vascular assessments can offer a comprehensive evaluation of cardiovascular risk.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
244
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
71